These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22083058)

  • 1. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia.
    Fox KA; Longo M; Tamayo E; Kechichian T; Bytautiene E; Hankins GD; Saade GR; Costantine MM
    Am J Obstet Gynecol; 2011 Oct; 205(4):366.e1-5. PubMed ID: 22083058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model.
    McDonnold M; Tamayo E; Kechichian T; Gamble P; Longo M; Hankins GD; Saade GR; Costantine MM
    Am J Obstet Gynecol; 2014 Jun; 210(6):542.e1-7. PubMed ID: 24412113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia.
    Saad AF; Diken ZM; Kechichian TB; Clark SM; Olson GL; Saade GR; Costantine MM
    Reprod Sci; 2016 Nov; 23(11):1593-1599. PubMed ID: 27170663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia.
    Costantine MM; Tamayo E; Lu F; Bytautiene E; Longo M; Hankins GDV; Saade GR
    Obstet Gynecol; 2010 Jul; 116(1):114-120. PubMed ID: 20567176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model.
    Byers BD; Betancourt A; Lu F; Hankins GD; Longo M; Saade GR; Bytautiene E
    Am J Obstet Gynecol; 2009 Apr; 200(4):432.e1-7. PubMed ID: 19318153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
    Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
    Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
    Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
    Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
    Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of complement component C1q in the onset of preeclampsia in mice.
    Singh J; Ahmed A; Girardi G
    Hypertension; 2011 Oct; 58(4):716-24. PubMed ID: 21859968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.
    Ahmed A; Williams DJ; Cheed V; Middleton LJ; Ahmad S; Wang K; Vince AT; Hewett P; Spencer K; Khan KS; Daniels JP;
    BJOG; 2020 Mar; 127(4):478-488. PubMed ID: 31715077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia.
    Zhou Q; Qiao FY; Zhao C; Liu HY
    Cell Biol Int; 2011 Jan; 35(1):61-6. PubMed ID: 20828367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.